Allergan continues R&D, expanding indications

With a changing landscape for innovation and research and development strategies for most large companies in ophthalmology and aesthetics, Healio.com interviewed Julian S. Gangolli, corporate vice president and president of North America at Allergan, to find out the latest approaches Allergan is taking in the industry.

Full Story →